Antipsychotic drugs are the most common treatment for schizophrenia, some may require a short course whereas others may require them for a life time or face reoccurrence of symptoms - there are two types:
Typical antipsychotics - first generation, used more often
Atypical antipsychotics - second generation, may be used if symptoms do not improve
Typical antipsychotics - 1st generation, e.g. Chlorpromazine
Typical antipsychotics such as Chlorpromazine are dopamine antagonists, they reduce levels of DA activity in the brain
Chlorpromazine also works by binding to the D2 receptors on post synaptic neurons to reduce the action of dopamine - this reduces dopamine activity levels and results in a reduction in positive symptoms, such as hallucinations
They are also used as a sedative and can be used to calm patients
Atypical antipsychotics - 2nd generation, e.g. Clozapine
Atypical antipsychotics such as Clozapine act upon both dopamine and serotonin
Clozapine also works by binding to the D2 receptors (dopamine antagonists) on post synaptic neurons to reduce the action of dopamine - this reduces dopamine activity levels and results in a reduction in positive symptoms, such as hallucinations
They also act as agonists upon serotonin receptor sites to increase serotonin activity levels - this reduces negative symptoms such as a lack of emotions as it helps to improve mood and reduce depression and anxiety in patients
Atypical antipsychotics are associated with agranulocytosis, which is a blood condition where there are low levels of white blood cells, preventing an individual fighting off disease and illness
If prescribed clozapine, patients will be regularly monitored for signs of agranulocytosis by having blood tests
Only prescribed if typical antipsychotics are not effective or if the patient has severe negative side effects, e.g. suicidal ideation
Typical antipsychotics can give patients parkinsonism, which affects their motor movements and can be quite distressing to a previously fit and able individual